Estrogen receptor beta expression in triple negative breast cancers is not associated with recurrence or survival.

Elena A TakanoMelissa M YounesKatie MeehanLisa SpaldingMax YanPrue AllanStephen B FoxAndy RedfernDavid CloustonGraham G GilesElizabeth L ChristieRobin L AndersonMagnus ZethovenKelly-Anne PhillipsKylie GorringeKara L Britt

Published in: BMC cancer (2023)

Our data indicate that ERβ1 expression in TNBC tumours does not associate with prognosis.

Keyphrases

estrogen receptor
poor prognosis
free survival
machine learning